Gene therapy in the United States: a five-year status report.
about
Cellular Senescence:Ex Vivop53-Dependent Asymmetric Cell KineticsExpression of thymidine kinase mediated by a novel non-viral delivery system under the control of vascular endothelial growth factor receptor 2 promoter selectively kills human umbilical vein endothelial cells.Recombinant, replication-defective adenovirus gene transfer vectors induce cell cycle dysregulation and inappropriate expression of cyclin proteins.A gene therapy for cancer using intramuscular injection of plasmid DNA encoding interferon alpha.Amphotropic murine leukemia viruses induce spongiform encephalomyelopathy.Pleuro-pulmonary tumours detected by clinical and chest X-ray analyses in rats transplanted with mesothelioma cells.Gene therapy for malignant brain tumors.Minimal requirement for a lentivirus vector based on human immunodeficiency virus type 1.Development of nanosomes using high-pressure homogenization for gene therapy.Separating lysozyme from bacteriophage P22 in two-phase aqueous micellar systems.Influence of lipophilic groups in cationic alpha-helical peptides on their abilities to bind with DNA and deliver genes into cells.Expectations and beliefs in science communication: Learning from three European gene therapy discussions of the early 1990s.Understanding viral partitioning in two-phase aqueous nonionic micellar systems: 1. Role of attractive interactions between viruses and micelles.Understanding viral partitioning in two-phase aqueous nonionic micellar systems: 2. Effect of entrained micelle-poor domains.Comparison of gene therapy with the herpes simplex virus thymidine kinase gene and the bacterial cytosine deaminase gene for the treatment of hepatocellular carcinoma.Complete cure of established murine hepatocellular carcinoma is achievable by repeated injections of retroviruses carrying the herpes simplex virus thymidine kinase gene.Dynamic changes in the characteristics of cationic lipidic vectors after exposure to mouse serum: implications for intravenous lipofection.Retrovirus-mediated transfer of a suicide gene into lens epithelial cells in vitro and in an experimental model of posterior capsule opacification.Amelioration of established collagen induced arthritis by systemic IL-10 gene delivery.Liposome-mediated, nonviral gene transfer induces a systemic inflammatory response which can exacerbate pre-existing inflammation.Genetic research as therapy: implications of "gene therapy" for informed consent.Gene therapy bio-safety: scientific and regulatory issues.Genetics and bioethics: how our thinking has changed since 1969.
P2860
Q24803348-E1A5F6A1-FB7C-419D-A912-73C5920471B9Q30489811-4010CDCE-82F8-4452-99B5-F4827A91F3A8Q33785925-DCD59492-A8BD-4D63-8E7C-D3786E6C525DQ35000575-8E7AD952-1DE2-4CE9-B843-ADC4CB268E1BQ36159756-E252AC19-5123-468D-9135-2ACFB1F4F0BFQ36620032-D4C4A11D-C2FA-4F42-B4EE-F988F2C6EEB9Q37610257-EF514A90-FC57-43C1-929A-5AF0A6F19304Q39577503-EE1B6EE3-C5DA-4BCF-BECF-B3B655135FF0Q39663075-1504439A-8DBD-4363-A7FC-F5C51FA9877BQ40706929-A5465333-0C04-4070-8B57-004013538027Q40921641-0C694AE2-6E05-469D-9CD4-849ED9FE34EDQ42696930-6ABA536D-339A-478D-8ED3-CFC001AB87D2Q43900070-983FD7C8-E33E-4E93-85C8-ED99D60CBF7EQ43900073-A7CFB108-D2DA-4D96-B273-37544B19C0F0Q45746250-0A53C578-6426-41D6-B6B7-80DBABF5FCDEQ45747425-7EE760A5-EEBE-49E4-B8EA-D83F507AC277Q45862123-6026CB2A-B3DC-4411-89A6-B719DAD1B7B3Q45863293-F1FD977F-831C-4057-AB55-8208F447549EQ45868500-F3EF7E3E-F650-4065-B659-17E9558B3115Q45870694-291CAD65-C707-4701-BA7F-638F76299FCCQ45872245-2434EE6C-7CB8-43F1-98A2-1A6325349ED0Q45887710-C05CB820-BCAF-4D71-8609-DC5C6CAA5E43Q48493269-05D29849-2081-46A0-B27B-21C06C470D36
P2860
Gene therapy in the United States: a five-year status report.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Gene therapy in the United States: a five-year status report.
@en
type
label
Gene therapy in the United States: a five-year status report.
@en
prefLabel
Gene therapy in the United States: a five-year status report.
@en
P2093
P1433
P1476
Gene therapy in the United States: a five-year status report.
@en
P2093
Erickson R
Motulsky AG
Samulski J
P304
P356
10.1089/HUM.1996.7.14-1781
P577
1996-09-01T00:00:00Z